Publication | Closed Access
177Lu-DOTATATE Therapy in Radioiodine-refractory Differentiated Thyroid Cancer
33
Citations
13
References
2018
Year
In this case study of five patients, Lu-DOTATATE therapy showed only heterogeneous response and efficacy in RrDTC patients despite good lesional uptake in pre-therapeutic PET.
| Year | Citations | |
|---|---|---|
Page 1
Page 1